Menu

Blog

Page 21

Feb 26, 2024

Drug Repairs Systems that Remove Alzheimer’s-Causing Waste From the Brain, Study Shows

Posted by in categories: biotech/medical, neuroscience

A team of Rutgers undergraduates has shown that an experimental drug known as Yoda1 may help drain cranial waste plus neurotoxins that cause Alzheimer’s disease and other forms of dementia.


Rutgers study led by undergrads and gap-year students breaks ground in the field of neuroscience and suggests experimental medication could treat dementia.

Feb 25, 2024

AI chatbots show human-like personality and decision-making traits, study finds

Posted by in category: robotics/AI

🤖 🧠 💡


A study in PNAS evaluates AI chatbots against human benchmarks, revealing that AI exhibits human-like behaviors and personality traits, with ChatGPT-4 closely mirroring human responses in strategic decision-making and personality assessments.

Feb 25, 2024

These major companies are using AI to snoop through employees’ messages, report reveals

Posted by in category: robotics/AI

Lydia Hu reports on the latest artificial intelligence news that major companies are using a new software to monitor employee conversations.

Feb 25, 2024

Galactic Wave May Have Crossed Paths With Earth, Scientists Find

Posted by in category: space

The more we learn about Earth’s past, the wilder it gets.


Known as the Radcliffe Wave, astronomers have discovered that this chain of stars, gas, and dust is propagating like a wave, too.

Feb 25, 2024

Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer

Posted by in categories: biotech/medical, innovation

“This trial has changed the lives of people with mesothelioma, allowing us to live longer,” said one of the patients who benefited from the drug. The 80-year-old, who wished to remain anonymous, won compensation from his former employer after being exposed to asbestos in a factory in the 1970s.

He was given four months to live, but thanks to the trial is still alive five years later. “I have five grandchildren and two great-grandchildren now – I wouldn’t want to miss all that,” he said.

The breakthrough is significant, experts say, because mesothelioma has one of the lowest survival rates of any cancer. The new drug, ADI-PEG20 (pegargiminase), is the first of its kind to be successfully combined with chemotherapy in 20 years.

Feb 25, 2024

Now Means Nothing

Posted by in category: futurism

Time depends on speed and mass, which means it’s not as consistent as we think.

Feb 25, 2024

The Last Piece of Our Genome: Sequencing the Y Chromosome

Posted by in categories: biotech/medical, genetics, health

Groundbreaking research led by a global group of over 100 researchers will enable a more in-depth exploration of human genetic variation as fully sequencing the Y chromosome, a feat that has challenged scientists for years, has been accomplished for the first time. In this interview, we speak to Dylan Taylor about this impactful research and how it may shape our understanding of human genetics.

Please could you introduce yourself and your current research activities?

I am Dylan Taylor, a Ph.D. candidate and NIH F31 fellow in the Department of Biology at Johns Hopkins University. My work with the T2T consortium focuses on exploring how a complete reference genome can improve our ability to study human genetic variation and how it impacts human traits and health.

Feb 25, 2024

Genomic evidence for rediploidization and adaptive evolution following the whole-genome triplication

Posted by in categories: biotech/medical, evolution

Polyploidization-rediploidization process plays an important role in plant adaptive evolution. Here, the authors assemble the genomes of mangrove species Sonneratia alba and its inland relative Lagerstroemia speciosa, and reveal genomic evidence for rediploidization and adaptive evolution after the whole-genome triplication.

Feb 25, 2024

Single-molecule RNA sizing enables quantitative analysis of alternative transcription termination

Posted by in category: futurism

The development of RNA technologies demands accurate assessment of transcript size and heterogeneity. Here, authors report a nanopore-based approach to study full-length RNA transcripts at the single-molecule level, identify premature transcription termination and study rolling-circle transcription.

Feb 25, 2024

René Descartes’ Legacy: The Persistence of Mind-Body Dualism

Posted by in category: neuroscience

René Descartes’ mind-body dualism—the view that the mind and body are different kinds of things—haunts cognitive science to this day.

Page 21 of 10,679First1819202122232425Last